Jiangsu Nanfang Medical (SHG:603880) — Market Cap & Net Worth
Market Cap & Net Worth: Jiangsu Nanfang Medical (603880)
Jiangsu Nanfang Medical (SHG:603880) has a market capitalization of $318.49 Million (CN¥2.18 Billion) as of May 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #14719 globally and #4570 in its home market, demonstrating a 19.52% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jiangsu Nanfang Medical's stock price CN¥7.53 by its total outstanding shares 289042000 (289.04 Million). Analyse cash flow conversion of Jiangsu Nanfang Medical to see how efficiently the company converts income to cash.
Jiangsu Nanfang Medical Market Cap History: 2017 to 2026
Jiangsu Nanfang Medical's market capitalization history from 2017 to 2026. Data shows growth from $362.70 Million to $318.49 Million (3.30% CAGR).
Jiangsu Nanfang Medical Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jiangsu Nanfang Medical's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.31x
Jiangsu Nanfang Medical's market cap is 0.31 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $362.70 Million | $488.71 Million | $47.60 Million | 0.74x | 7.62x |
| 2018 | $220.50 Million | $479.82 Million | $39.25 Million | 0.46x | 5.62x |
| 2019 | $285.89 Million | $491.69 Million | $28.05 Million | 0.58x | 10.19x |
| 2020 | $404.84 Million | $1.07 Billion | $98.07 Million | 0.38x | 4.13x |
| 2021 | $302.84 Million | $527.44 Million | -$23.04 Million | 0.57x | N/A |
| 2022 | $262.23 Million | $545.37 Million | -$14.94 Million | 0.48x | N/A |
| 2023 | $215.29 Million | $600.10 Million | -$147.42 Million | 0.36x | N/A |
| 2024 | $183.99 Million | $602.62 Million | -$190.67 Million | 0.31x | N/A |
Competitor Companies of 603880 by Market Capitalization
Companies near Jiangsu Nanfang Medical in the global market cap rankings as of May 7, 2026.
Key companies related to Jiangsu Nanfang Medical by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #137 globally with a market cap of $160.42 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #259 globally with a market cap of $95.66 Billion USD ( €81.82 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #274 globally with a market cap of $93.24 Billion USD ( €79.76 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #527 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #137 | Intuitive Surgical Inc | NASDAQ:ISRG | $160.42 Billion | $451.73 |
| #259 | EssilorLuxottica S. A. | PA:EL | $95.66 Billion | €176.70 |
| #274 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $93.24 Billion | €89.50 |
| #527 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Jiangsu Nanfang Medical Historical Marketcap From 2017 to 2026
Between 2017 and today, Jiangsu Nanfang Medical's market cap moved from $362.70 Million to $ 318.49 Million, with a yearly change of 3.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥318.49 Million | +20.87% |
| 2025 | CN¥263.50 Million | +43.22% |
| 2024 | CN¥183.99 Million | -14.54% |
| 2023 | CN¥215.29 Million | -17.90% |
| 2022 | CN¥262.23 Million | -13.41% |
| 2021 | CN¥302.84 Million | -25.19% |
| 2020 | CN¥404.84 Million | +41.61% |
| 2019 | CN¥285.89 Million | +29.65% |
| 2018 | CN¥220.50 Million | -39.21% |
| 2017 | CN¥362.70 Million | -- |
End of Day Market Cap According to Different Sources
On May 7th, 2026 the market cap of Jiangsu Nanfang Medical was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $318.49 Million USD |
| MoneyControl | $318.49 Million USD |
| MarketWatch | $318.49 Million USD |
| marketcap.company | $318.49 Million USD |
| Reuters | $318.49 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jiangsu Nanfang Medical
Jiangsu Nanfang Medical Co., Ltd. engages in the research and development, production, and sale of transdermal, medical proof fabrics, adhesive tapes and bandages, sports protection, first-aid kits, and care products in China and internationally. It offers medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical … Read more